Screener
Revolution Medicines, Inc. RVMD Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Revolution Medicines, Inc.’s reported figures.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
FAQ
- What is Revolution Medicines, Inc.'s free cash flow?
- Revolution Medicines, Inc. (RVMD) reported free cash flow of -$389.61M in Q2 2026.
- How has Revolution Medicines, Inc.'s free cash flow changed year-over-year?
- Revolution Medicines, Inc.'s free cash flow decreased by 70.0% year-over-year, from -$229.21M to -$389.61M.
- What is the long-term trend for Revolution Medicines, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s free cash flow has grown at a 56.1% compound annual growth rate (CAGR), from -$153.71M to -$913.73M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Revolution Medicines, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude